COVID-19 Impact on Global Subcutaneous Immunotherapy Market Size, Status and Forecast 2020-2026
Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Subcutaneous Immunotherapy market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Subcutaneous Immunotherapy industry.
Based on our recent survey, we have several different scenarios about the Subcutaneous Immunotherapy YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Subcutaneous Immunotherapy will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Subcutaneous Immunotherapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Subcutaneous Immunotherapy market in terms of revenue.
Players, stakeholders, and other participants in the global Subcutaneous Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Subcutaneous Immunotherapy market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Subcutaneous Immunotherapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Subcutaneous Immunotherapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Subcutaneous Immunotherapy market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Subcutaneous Immunotherapy market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Subcutaneous Immunotherapy industry.
Based on our recent survey, we have several different scenarios about the Subcutaneous Immunotherapy YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Subcutaneous Immunotherapy will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Subcutaneous Immunotherapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Subcutaneous Immunotherapy market in terms of revenue.
Players, stakeholders, and other participants in the global Subcutaneous Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Subcutaneous Immunotherapy market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Subcutaneous Immunotherapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Subcutaneous Immunotherapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Subcutaneous Immunotherapy market.
The following players are covered in this report:
- Anergis
- HAL Allergy Group
- Merck
- Allergy Therapeutics
- ALK-Abello
- Stallergenes Greer
- Laboratorios LETI
- Asthma
- Allergic Rhinitis
- Venom Allergy
- Food Allergy
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Subcutaneous Immunotherapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Subcutaneous Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Asthma
1.4.3 Allergic Rhinitis
1.4.4 Venom Allergy
1.4.5 Food Allergy
1.5 Market by Application
1.5.1 Global Subcutaneous Immunotherapy Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Subcutaneous Immunotherapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Subcutaneous Immunotherapy Industry
1.6.1.1 Subcutaneous Immunotherapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Subcutaneous Immunotherapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Subcutaneous Immunotherapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Subcutaneous Immunotherapy Market Perspective (2015-2026)
2.2 Subcutaneous Immunotherapy Growth Trends by Regions
2.2.1 Subcutaneous Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Subcutaneous Immunotherapy Historic Market Share by Regions (2015-2020)
2.2.3 Subcutaneous Immunotherapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Subcutaneous Immunotherapy Market Growth Strategy
2.3.6 Primary Interviews with Key Subcutaneous Immunotherapy Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Subcutaneous Immunotherapy Players by Market Size
3.1.1 Global Top Subcutaneous Immunotherapy Players by Revenue (2015-2020)
3.1.2 Global Subcutaneous Immunotherapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Subcutaneous Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Subcutaneous Immunotherapy Market Concentration Ratio
3.2.1 Global Subcutaneous Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Subcutaneous Immunotherapy Revenue in 2019
3.3 Subcutaneous Immunotherapy Key Players Head office and Area Served
3.4 Key Players Subcutaneous Immunotherapy Product Solution and Service
3.5 Date of Enter into Subcutaneous Immunotherapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Subcutaneous Immunotherapy Historic Market Size by Type (2015-2020)
4.2 Global Subcutaneous Immunotherapy Forecasted Market Size by Type (2021-2026)
5 SUBCUTANEOUS IMMUNOTHERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Subcutaneous Immunotherapy Market Size by Application (2015-2020)
5.2 Global Subcutaneous Immunotherapy Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Subcutaneous Immunotherapy Market Size (2015-2020)
6.2 Subcutaneous Immunotherapy Key Players in North America (2019-2020)
6.3 North America Subcutaneous Immunotherapy Market Size by Type (2015-2020)
6.4 North America Subcutaneous Immunotherapy Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Subcutaneous Immunotherapy Market Size (2015-2020)
7.2 Subcutaneous Immunotherapy Key Players in Europe (2019-2020)
7.3 Europe Subcutaneous Immunotherapy Market Size by Type (2015-2020)
7.4 Europe Subcutaneous Immunotherapy Market Size by Application (2015-2020)
8 CHINA
8.1 China Subcutaneous Immunotherapy Market Size (2015-2020)
8.2 Subcutaneous Immunotherapy Key Players in China (2019-2020)
8.3 China Subcutaneous Immunotherapy Market Size by Type (2015-2020)
8.4 China Subcutaneous Immunotherapy Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Subcutaneous Immunotherapy Market Size (2015-2020)
9.2 Subcutaneous Immunotherapy Key Players in Japan (2019-2020)
9.3 Japan Subcutaneous Immunotherapy Market Size by Type (2015-2020)
9.4 Japan Subcutaneous Immunotherapy Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Subcutaneous Immunotherapy Market Size (2015-2020)
10.2 Subcutaneous Immunotherapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Subcutaneous Immunotherapy Market Size by Type (2015-2020)
10.4 Southeast Asia Subcutaneous Immunotherapy Market Size by Application (2015-2020)
11 INDIA
11.1 India Subcutaneous Immunotherapy Market Size (2015-2020)
11.2 Subcutaneous Immunotherapy Key Players in India (2019-2020)
11.3 India Subcutaneous Immunotherapy Market Size by Type (2015-2020)
11.4 India Subcutaneous Immunotherapy Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Subcutaneous Immunotherapy Market Size (2015-2020)
12.2 Subcutaneous Immunotherapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Subcutaneous Immunotherapy Market Size by Type (2015-2020)
12.4 Central & South America Subcutaneous Immunotherapy Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Anergis
13.1.1 Anergis Company Details
13.1.2 Anergis Business Overview and Its Total Revenue
13.1.3 Anergis Subcutaneous Immunotherapy Introduction
13.1.4 Anergis Revenue in Subcutaneous Immunotherapy Business (2015-2020))
13.1.5 Anergis Recent Development
13.2 HAL Allergy Group
13.2.1 HAL Allergy Group Company Details
13.2.2 HAL Allergy Group Business Overview and Its Total Revenue
13.2.3 HAL Allergy Group Subcutaneous Immunotherapy Introduction
13.2.4 HAL Allergy Group Revenue in Subcutaneous Immunotherapy Business (2015-2020)
13.2.5 HAL Allergy Group Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview and Its Total Revenue
13.3.3 Merck Subcutaneous Immunotherapy Introduction
13.3.4 Merck Revenue in Subcutaneous Immunotherapy Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Allergy Therapeutics
13.4.1 Allergy Therapeutics Company Details
13.4.2 Allergy Therapeutics Business Overview and Its Total Revenue
13.4.3 Allergy Therapeutics Subcutaneous Immunotherapy Introduction
13.4.4 Allergy Therapeutics Revenue in Subcutaneous Immunotherapy Business (2015-2020)
13.4.5 Allergy Therapeutics Recent Development
13.5 ALK-Abello
13.5.1 ALK-Abello Company Details
13.5.2 ALK-Abello Business Overview and Its Total Revenue
13.5.3 ALK-Abello Subcutaneous Immunotherapy Introduction
13.5.4 ALK-Abello Revenue in Subcutaneous Immunotherapy Business (2015-2020)
13.5.5 ALK-Abello Recent Development
13.6 Stallergenes Greer
13.6.1 Stallergenes Greer Company Details
13.6.2 Stallergenes Greer Business Overview and Its Total Revenue
13.6.3 Stallergenes Greer Subcutaneous Immunotherapy Introduction
13.6.4 Stallergenes Greer Revenue in Subcutaneous Immunotherapy Business (2015-2020)
13.6.5 Stallergenes Greer Recent Development
13.7 Laboratorios LETI
13.7.1 Laboratorios LETI Company Details
13.7.2 Laboratorios LETI Business Overview and Its Total Revenue
13.7.3 Laboratorios LETI Subcutaneous Immunotherapy Introduction
13.7.4 Laboratorios LETI Revenue in Subcutaneous Immunotherapy Business (2015-2020)
13.7.5 Laboratorios LETI Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Subcutaneous Immunotherapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Subcutaneous Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Asthma
1.4.3 Allergic Rhinitis
1.4.4 Venom Allergy
1.4.5 Food Allergy
1.5 Market by Application
1.5.1 Global Subcutaneous Immunotherapy Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Subcutaneous Immunotherapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Subcutaneous Immunotherapy Industry
1.6.1.1 Subcutaneous Immunotherapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Subcutaneous Immunotherapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Subcutaneous Immunotherapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Subcutaneous Immunotherapy Market Perspective (2015-2026)
2.2 Subcutaneous Immunotherapy Growth Trends by Regions
2.2.1 Subcutaneous Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Subcutaneous Immunotherapy Historic Market Share by Regions (2015-2020)
2.2.3 Subcutaneous Immunotherapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Subcutaneous Immunotherapy Market Growth Strategy
2.3.6 Primary Interviews with Key Subcutaneous Immunotherapy Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Subcutaneous Immunotherapy Players by Market Size
3.1.1 Global Top Subcutaneous Immunotherapy Players by Revenue (2015-2020)
3.1.2 Global Subcutaneous Immunotherapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Subcutaneous Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Subcutaneous Immunotherapy Market Concentration Ratio
3.2.1 Global Subcutaneous Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Subcutaneous Immunotherapy Revenue in 2019
3.3 Subcutaneous Immunotherapy Key Players Head office and Area Served
3.4 Key Players Subcutaneous Immunotherapy Product Solution and Service
3.5 Date of Enter into Subcutaneous Immunotherapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Subcutaneous Immunotherapy Historic Market Size by Type (2015-2020)
4.2 Global Subcutaneous Immunotherapy Forecasted Market Size by Type (2021-2026)
5 SUBCUTANEOUS IMMUNOTHERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Subcutaneous Immunotherapy Market Size by Application (2015-2020)
5.2 Global Subcutaneous Immunotherapy Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Subcutaneous Immunotherapy Market Size (2015-2020)
6.2 Subcutaneous Immunotherapy Key Players in North America (2019-2020)
6.3 North America Subcutaneous Immunotherapy Market Size by Type (2015-2020)
6.4 North America Subcutaneous Immunotherapy Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Subcutaneous Immunotherapy Market Size (2015-2020)
7.2 Subcutaneous Immunotherapy Key Players in Europe (2019-2020)
7.3 Europe Subcutaneous Immunotherapy Market Size by Type (2015-2020)
7.4 Europe Subcutaneous Immunotherapy Market Size by Application (2015-2020)
8 CHINA
8.1 China Subcutaneous Immunotherapy Market Size (2015-2020)
8.2 Subcutaneous Immunotherapy Key Players in China (2019-2020)
8.3 China Subcutaneous Immunotherapy Market Size by Type (2015-2020)
8.4 China Subcutaneous Immunotherapy Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Subcutaneous Immunotherapy Market Size (2015-2020)
9.2 Subcutaneous Immunotherapy Key Players in Japan (2019-2020)
9.3 Japan Subcutaneous Immunotherapy Market Size by Type (2015-2020)
9.4 Japan Subcutaneous Immunotherapy Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Subcutaneous Immunotherapy Market Size (2015-2020)
10.2 Subcutaneous Immunotherapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Subcutaneous Immunotherapy Market Size by Type (2015-2020)
10.4 Southeast Asia Subcutaneous Immunotherapy Market Size by Application (2015-2020)
11 INDIA
11.1 India Subcutaneous Immunotherapy Market Size (2015-2020)
11.2 Subcutaneous Immunotherapy Key Players in India (2019-2020)
11.3 India Subcutaneous Immunotherapy Market Size by Type (2015-2020)
11.4 India Subcutaneous Immunotherapy Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Subcutaneous Immunotherapy Market Size (2015-2020)
12.2 Subcutaneous Immunotherapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Subcutaneous Immunotherapy Market Size by Type (2015-2020)
12.4 Central & South America Subcutaneous Immunotherapy Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Anergis
13.1.1 Anergis Company Details
13.1.2 Anergis Business Overview and Its Total Revenue
13.1.3 Anergis Subcutaneous Immunotherapy Introduction
13.1.4 Anergis Revenue in Subcutaneous Immunotherapy Business (2015-2020))
13.1.5 Anergis Recent Development
13.2 HAL Allergy Group
13.2.1 HAL Allergy Group Company Details
13.2.2 HAL Allergy Group Business Overview and Its Total Revenue
13.2.3 HAL Allergy Group Subcutaneous Immunotherapy Introduction
13.2.4 HAL Allergy Group Revenue in Subcutaneous Immunotherapy Business (2015-2020)
13.2.5 HAL Allergy Group Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview and Its Total Revenue
13.3.3 Merck Subcutaneous Immunotherapy Introduction
13.3.4 Merck Revenue in Subcutaneous Immunotherapy Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Allergy Therapeutics
13.4.1 Allergy Therapeutics Company Details
13.4.2 Allergy Therapeutics Business Overview and Its Total Revenue
13.4.3 Allergy Therapeutics Subcutaneous Immunotherapy Introduction
13.4.4 Allergy Therapeutics Revenue in Subcutaneous Immunotherapy Business (2015-2020)
13.4.5 Allergy Therapeutics Recent Development
13.5 ALK-Abello
13.5.1 ALK-Abello Company Details
13.5.2 ALK-Abello Business Overview and Its Total Revenue
13.5.3 ALK-Abello Subcutaneous Immunotherapy Introduction
13.5.4 ALK-Abello Revenue in Subcutaneous Immunotherapy Business (2015-2020)
13.5.5 ALK-Abello Recent Development
13.6 Stallergenes Greer
13.6.1 Stallergenes Greer Company Details
13.6.2 Stallergenes Greer Business Overview and Its Total Revenue
13.6.3 Stallergenes Greer Subcutaneous Immunotherapy Introduction
13.6.4 Stallergenes Greer Revenue in Subcutaneous Immunotherapy Business (2015-2020)
13.6.5 Stallergenes Greer Recent Development
13.7 Laboratorios LETI
13.7.1 Laboratorios LETI Company Details
13.7.2 Laboratorios LETI Business Overview and Its Total Revenue
13.7.3 Laboratorios LETI Subcutaneous Immunotherapy Introduction
13.7.4 Laboratorios LETI Revenue in Subcutaneous Immunotherapy Business (2015-2020)
13.7.5 Laboratorios LETI Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Subcutaneous Immunotherapy Key Market Segments
Table 2. Key Players Covered: Ranking by Subcutaneous Immunotherapy Revenue
Table 3. Ranking of Global Top Subcutaneous Immunotherapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Subcutaneous Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Asthma
Table 6. Key Players of Allergic Rhinitis
Table 7. Key Players of Venom Allergy
Table 8. Key Players of Food Allergy
Table 9. COVID-19 Impact Global Market: (Four Subcutaneous Immunotherapy Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Subcutaneous Immunotherapy Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Subcutaneous Immunotherapy Players to Combat Covid-19 Impact
Table 14. Global Subcutaneous Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Subcutaneous Immunotherapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Subcutaneous Immunotherapy Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Subcutaneous Immunotherapy Market Share by Regions (2015-2020)
Table 18. Global Subcutaneous Immunotherapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Subcutaneous Immunotherapy Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Subcutaneous Immunotherapy Market Growth Strategy
Table 24. Main Points Interviewed from Key Subcutaneous Immunotherapy Players
Table 25. Global Subcutaneous Immunotherapy Revenue by Players (2015-2020) (Million US$)
Table 26. Global Subcutaneous Immunotherapy Market Share by Players (2015-2020)
Table 27. Global Top Subcutaneous Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Immunotherapy as of 2019)
Table 28. Global Subcutaneous Immunotherapy by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Subcutaneous Immunotherapy Product Solution and Service
Table 31. Date of Enter into Subcutaneous Immunotherapy Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 34. Global Subcutaneous Immunotherapy Market Size Share by Type (2015-2020)
Table 35. Global Subcutaneous Immunotherapy Revenue Market Share by Type (2021-2026)
Table 36. Global Subcutaneous Immunotherapy Market Size Share by Application (2015-2020)
Table 37. Global Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 38. Global Subcutaneous Immunotherapy Market Size Share by Application (2021-2026)
Table 39. North America Key Players Subcutaneous Immunotherapy Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Subcutaneous Immunotherapy Market Share (2019-2020)
Table 41. North America Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 42. North America Subcutaneous Immunotherapy Market Share by Type (2015-2020)
Table 43. North America Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 44. North America Subcutaneous Immunotherapy Market Share by Application (2015-2020)
Table 45. Europe Key Players Subcutaneous Immunotherapy Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Subcutaneous Immunotherapy Market Share (2019-2020)
Table 47. Europe Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Subcutaneous Immunotherapy Market Share by Type (2015-2020)
Table 49. Europe Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Subcutaneous Immunotherapy Market Share by Application (2015-2020)
Table 51. China Key Players Subcutaneous Immunotherapy Revenue (2019-2020) (Million US$)
Table 52. China Key Players Subcutaneous Immunotherapy Market Share (2019-2020)
Table 53. China Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 54. China Subcutaneous Immunotherapy Market Share by Type (2015-2020)
Table 55. China Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 56. China Subcutaneous Immunotherapy Market Share by Application (2015-2020)
Table 57. Japan Key Players Subcutaneous Immunotherapy Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Subcutaneous Immunotherapy Market Share (2019-2020)
Table 59. Japan Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Subcutaneous Immunotherapy Market Share by Type (2015-2020)
Table 61. Japan Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Subcutaneous Immunotherapy Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Subcutaneous Immunotherapy Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Subcutaneous Immunotherapy Market Share (2019-2020)
Table 65. Southeast Asia Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Subcutaneous Immunotherapy Market Share by Type (2015-2020)
Table 67. Southeast Asia Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Subcutaneous Immunotherapy Market Share by Application (2015-2020)
Table 69. India Key Players Subcutaneous Immunotherapy Revenue (2019-2020) (Million US$)
Table 70. India Key Players Subcutaneous Immunotherapy Market Share (2019-2020)
Table 71. India Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 72. India Subcutaneous Immunotherapy Market Share by Type (2015-2020)
Table 73. India Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 74. India Subcutaneous Immunotherapy Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Subcutaneous Immunotherapy Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Subcutaneous Immunotherapy Market Share (2019-2020)
Table 77. Central & South America Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Subcutaneous Immunotherapy Market Share by Type (2015-2020)
Table 79. Central & South America Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Subcutaneous Immunotherapy Market Share by Application (2015-2020)
Table 81. Anergis Company Details
Table 82. Anergis Business Overview
Table 83. Anergis Product
Table 84. Anergis Revenue in Subcutaneous Immunotherapy Business (2015-2020) (Million US$)
Table 85. Anergis Recent Development
Table 86. HAL Allergy Group Company Details
Table 87. HAL Allergy Group Business Overview
Table 88. HAL Allergy Group Product
Table 89. HAL Allergy Group Revenue in Subcutaneous Immunotherapy Business (2015-2020) (Million US$)
Table 90. HAL Allergy Group Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Product
Table 94. Merck Revenue in Subcutaneous Immunotherapy Business (2015-2020) (Million US$)
Table 95. Merck Recent Development
Table 96. Allergy Therapeutics Company Details
Table 97. Allergy Therapeutics Business Overview
Table 98. Allergy Therapeutics Product
Table 99. Allergy Therapeutics Revenue in Subcutaneous Immunotherapy Business (2015-2020) (Million US$)
Table 100. Allergy Therapeutics Recent Development
Table 101. ALK-Abello Company Details
Table 102. ALK-Abello Business Overview
Table 103. ALK-Abello Product
Table 104. ALK-Abello Revenue in Subcutaneous Immunotherapy Business (2015-2020) (Million US$)
Table 105. ALK-Abello Recent Development
Table 106. Stallergenes Greer Company Details
Table 107. Stallergenes Greer Business Overview
Table 108. Stallergenes Greer Product
Table 109. Stallergenes Greer Revenue in Subcutaneous Immunotherapy Business (2015-2020) (Million US$)
Table 110. Stallergenes Greer Recent Development
Table 111. Laboratorios LETI Company Details
Table 112. Laboratorios LETI Business Overview
Table 113. Laboratorios LETI Product
Table 114. Laboratorios LETI Revenue in Subcutaneous Immunotherapy Business (2015-2020) (Million US$)
Table 115. Laboratorios LETI Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 1. Subcutaneous Immunotherapy Key Market Segments
Table 2. Key Players Covered: Ranking by Subcutaneous Immunotherapy Revenue
Table 3. Ranking of Global Top Subcutaneous Immunotherapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Subcutaneous Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Asthma
Table 6. Key Players of Allergic Rhinitis
Table 7. Key Players of Venom Allergy
Table 8. Key Players of Food Allergy
Table 9. COVID-19 Impact Global Market: (Four Subcutaneous Immunotherapy Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Subcutaneous Immunotherapy Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Subcutaneous Immunotherapy Players to Combat Covid-19 Impact
Table 14. Global Subcutaneous Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Subcutaneous Immunotherapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Subcutaneous Immunotherapy Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Subcutaneous Immunotherapy Market Share by Regions (2015-2020)
Table 18. Global Subcutaneous Immunotherapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Subcutaneous Immunotherapy Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Subcutaneous Immunotherapy Market Growth Strategy
Table 24. Main Points Interviewed from Key Subcutaneous Immunotherapy Players
Table 25. Global Subcutaneous Immunotherapy Revenue by Players (2015-2020) (Million US$)
Table 26. Global Subcutaneous Immunotherapy Market Share by Players (2015-2020)
Table 27. Global Top Subcutaneous Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Immunotherapy as of 2019)
Table 28. Global Subcutaneous Immunotherapy by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Subcutaneous Immunotherapy Product Solution and Service
Table 31. Date of Enter into Subcutaneous Immunotherapy Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 34. Global Subcutaneous Immunotherapy Market Size Share by Type (2015-2020)
Table 35. Global Subcutaneous Immunotherapy Revenue Market Share by Type (2021-2026)
Table 36. Global Subcutaneous Immunotherapy Market Size Share by Application (2015-2020)
Table 37. Global Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 38. Global Subcutaneous Immunotherapy Market Size Share by Application (2021-2026)
Table 39. North America Key Players Subcutaneous Immunotherapy Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Subcutaneous Immunotherapy Market Share (2019-2020)
Table 41. North America Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 42. North America Subcutaneous Immunotherapy Market Share by Type (2015-2020)
Table 43. North America Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 44. North America Subcutaneous Immunotherapy Market Share by Application (2015-2020)
Table 45. Europe Key Players Subcutaneous Immunotherapy Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Subcutaneous Immunotherapy Market Share (2019-2020)
Table 47. Europe Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Subcutaneous Immunotherapy Market Share by Type (2015-2020)
Table 49. Europe Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Subcutaneous Immunotherapy Market Share by Application (2015-2020)
Table 51. China Key Players Subcutaneous Immunotherapy Revenue (2019-2020) (Million US$)
Table 52. China Key Players Subcutaneous Immunotherapy Market Share (2019-2020)
Table 53. China Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 54. China Subcutaneous Immunotherapy Market Share by Type (2015-2020)
Table 55. China Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 56. China Subcutaneous Immunotherapy Market Share by Application (2015-2020)
Table 57. Japan Key Players Subcutaneous Immunotherapy Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Subcutaneous Immunotherapy Market Share (2019-2020)
Table 59. Japan Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Subcutaneous Immunotherapy Market Share by Type (2015-2020)
Table 61. Japan Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Subcutaneous Immunotherapy Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Subcutaneous Immunotherapy Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Subcutaneous Immunotherapy Market Share (2019-2020)
Table 65. Southeast Asia Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Subcutaneous Immunotherapy Market Share by Type (2015-2020)
Table 67. Southeast Asia Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Subcutaneous Immunotherapy Market Share by Application (2015-2020)
Table 69. India Key Players Subcutaneous Immunotherapy Revenue (2019-2020) (Million US$)
Table 70. India Key Players Subcutaneous Immunotherapy Market Share (2019-2020)
Table 71. India Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 72. India Subcutaneous Immunotherapy Market Share by Type (2015-2020)
Table 73. India Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 74. India Subcutaneous Immunotherapy Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Subcutaneous Immunotherapy Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Subcutaneous Immunotherapy Market Share (2019-2020)
Table 77. Central & South America Subcutaneous Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Subcutaneous Immunotherapy Market Share by Type (2015-2020)
Table 79. Central & South America Subcutaneous Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Subcutaneous Immunotherapy Market Share by Application (2015-2020)
Table 81. Anergis Company Details
Table 82. Anergis Business Overview
Table 83. Anergis Product
Table 84. Anergis Revenue in Subcutaneous Immunotherapy Business (2015-2020) (Million US$)
Table 85. Anergis Recent Development
Table 86. HAL Allergy Group Company Details
Table 87. HAL Allergy Group Business Overview
Table 88. HAL Allergy Group Product
Table 89. HAL Allergy Group Revenue in Subcutaneous Immunotherapy Business (2015-2020) (Million US$)
Table 90. HAL Allergy Group Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Product
Table 94. Merck Revenue in Subcutaneous Immunotherapy Business (2015-2020) (Million US$)
Table 95. Merck Recent Development
Table 96. Allergy Therapeutics Company Details
Table 97. Allergy Therapeutics Business Overview
Table 98. Allergy Therapeutics Product
Table 99. Allergy Therapeutics Revenue in Subcutaneous Immunotherapy Business (2015-2020) (Million US$)
Table 100. Allergy Therapeutics Recent Development
Table 101. ALK-Abello Company Details
Table 102. ALK-Abello Business Overview
Table 103. ALK-Abello Product
Table 104. ALK-Abello Revenue in Subcutaneous Immunotherapy Business (2015-2020) (Million US$)
Table 105. ALK-Abello Recent Development
Table 106. Stallergenes Greer Company Details
Table 107. Stallergenes Greer Business Overview
Table 108. Stallergenes Greer Product
Table 109. Stallergenes Greer Revenue in Subcutaneous Immunotherapy Business (2015-2020) (Million US$)
Table 110. Stallergenes Greer Recent Development
Table 111. Laboratorios LETI Company Details
Table 112. Laboratorios LETI Business Overview
Table 113. Laboratorios LETI Product
Table 114. Laboratorios LETI Revenue in Subcutaneous Immunotherapy Business (2015-2020) (Million US$)
Table 115. Laboratorios LETI Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Subcutaneous Immunotherapy Market Share by Type: 2020 VS 2026
Figure 2. Asthma Features
Figure 3. Allergic Rhinitis Features
Figure 4. Venom Allergy Features
Figure 5. Food Allergy Features
Figure 6. Global Subcutaneous Immunotherapy Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Subcutaneous Immunotherapy Report Years Considered
Figure 11. Global Subcutaneous Immunotherapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Subcutaneous Immunotherapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Subcutaneous Immunotherapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Subcutaneous Immunotherapy Market Share by Players in 2019
Figure 16. Global Top Subcutaneous Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Immunotherapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Subcutaneous Immunotherapy Revenue in 2019
Figure 18. North America Subcutaneous Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Subcutaneous Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Subcutaneous Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Subcutaneous Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Subcutaneous Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Subcutaneous Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Subcutaneous Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Anergis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Anergis Revenue Growth Rate in Subcutaneous Immunotherapy Business (2015-2020)
Figure 27. HAL Allergy Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. HAL Allergy Group Revenue Growth Rate in Subcutaneous Immunotherapy Business (2015-2020)
Figure 29. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Merck Revenue Growth Rate in Subcutaneous Immunotherapy Business (2015-2020)
Figure 31. Allergy Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Allergy Therapeutics Revenue Growth Rate in Subcutaneous Immunotherapy Business (2015-2020)
Figure 33. ALK-Abello Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. ALK-Abello Revenue Growth Rate in Subcutaneous Immunotherapy Business (2015-2020)
Figure 35. Stallergenes Greer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Stallergenes Greer Revenue Growth Rate in Subcutaneous Immunotherapy Business (2015-2020)
Figure 37. Laboratorios LETI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Laboratorios LETI Revenue Growth Rate in Subcutaneous Immunotherapy Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Figure 1. Global Subcutaneous Immunotherapy Market Share by Type: 2020 VS 2026
Figure 2. Asthma Features
Figure 3. Allergic Rhinitis Features
Figure 4. Venom Allergy Features
Figure 5. Food Allergy Features
Figure 6. Global Subcutaneous Immunotherapy Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Subcutaneous Immunotherapy Report Years Considered
Figure 11. Global Subcutaneous Immunotherapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Subcutaneous Immunotherapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Subcutaneous Immunotherapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Subcutaneous Immunotherapy Market Share by Players in 2019
Figure 16. Global Top Subcutaneous Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Immunotherapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Subcutaneous Immunotherapy Revenue in 2019
Figure 18. North America Subcutaneous Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Subcutaneous Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Subcutaneous Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Subcutaneous Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Subcutaneous Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Subcutaneous Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Subcutaneous Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Anergis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Anergis Revenue Growth Rate in Subcutaneous Immunotherapy Business (2015-2020)
Figure 27. HAL Allergy Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. HAL Allergy Group Revenue Growth Rate in Subcutaneous Immunotherapy Business (2015-2020)
Figure 29. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Merck Revenue Growth Rate in Subcutaneous Immunotherapy Business (2015-2020)
Figure 31. Allergy Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Allergy Therapeutics Revenue Growth Rate in Subcutaneous Immunotherapy Business (2015-2020)
Figure 33. ALK-Abello Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. ALK-Abello Revenue Growth Rate in Subcutaneous Immunotherapy Business (2015-2020)
Figure 35. Stallergenes Greer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Stallergenes Greer Revenue Growth Rate in Subcutaneous Immunotherapy Business (2015-2020)
Figure 37. Laboratorios LETI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Laboratorios LETI Revenue Growth Rate in Subcutaneous Immunotherapy Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
